Surprisingly, while RPL3 alleviated obesity (Supplementary Figures S4A–D), it failed to improve serum cholesterol parameters (Supplementary Figures S4E–G). Here, RPL3 is linked to obesity due to melanocortin 4 receptor deficiency.